Does early sulfasalazine treatment provide long-term benefits to patients with juvenile idiopathic arthritis?: Commentary

Nature Clinical Practice Rheumatology

Volumn 4, Issue 7, 2008, Pages 344-345

  Ting, Tracy V ^a   Lovell, Daniel J ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; PLACEBO; SALAZOSULFAPYRIDINE;

ARTHRALGIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LONG TERM CARE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SHORT SURVEY; WELLBEING;

EID: 47149112637     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0819     Document Type: Short Survey

References (5)

1. Anderson JJ et al. (2000) Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration. Arthritis Rheum 43: 22-29
2. Quinn MA et al. (2001) The therapeutic approach of early intervention for rheumatoid arthritis: What is the evidence? Rheumatology (Oxford) 40: 1211-1220
3. Wallace CA (2006) Current management of JIA. Best Pract Res Clin Rheumatol 20: 279-300
4. Effectiveness of early aggressive drug therapy in poly-juvenile idiopathic arthritis. [http://www.cliniocatrials.gov/ct2/show/ NCT00443430?term=etanercept+and+JIA&rank=2] (accessed 9 April 2008)
5. Rappoff MA (2006) Management of adherence and chronic rheumatic disease in children and adolescents. Best Pract Res Clin Rheumatol 20 301-314